Cochlear Limited
CHEOYOTCHealthcare● Active
$35.07
+$0.17(+0.47%)
Market Cap$4.6B
P/E Ratio—
52W High$105.6
52W Low$31.82
Cochlear Limited (CHEOY) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CHEOY · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 11, 2026EPS Actual
$0.81
Revenue
$0.77B
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 11, 2026
After Market Close
CHEOY reports quarterly as a OTC-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q1 FY2026 | Feb 11, 2026 | — | $0.81 | — | $0.77B | — | — |
| — Q3 FY2025 | Aug 18, 2025 | — | $0.92 | — | $0.77B | — | — |
| — Q1 FY2025 | Feb 13, 2025 | — | $0.97 | — | $0.73B | — | — |
| — Q3 FY2024 | Aug 15, 2024 | — | $0.84 | — | $0.76B | — | — |
| — Q1 FY2024 | Feb 18, 2024 | — | $0.99 | — | $0.76B | — | — |
| — Q2 FY2023 | Jun 30, 2023 | — | $0.80 | — | $0.71B | — | — |
| — Q4 FY2022 | Dec 31, 2022 | — | $0.74 | — | $0.61B | — | — |
| — Q2 FY2022 | Jun 30, 2022 | — | $0.63 | — | $0.57B | — | — |
Q1 FY2026
Feb 11, 2026
EPS Actual
$0.81
EPS Est.
—
EPS Surpr.
—
Revenue
$0.77B
Q3 FY2025
Aug 18, 2025
EPS Actual
$0.92
EPS Est.
—
EPS Surpr.
—
Revenue
$0.77B
Q1 FY2025
Feb 13, 2025
EPS Actual
$0.97
EPS Est.
—
EPS Surpr.
—
Revenue
$0.73B
Q3 FY2024
Aug 15, 2024
EPS Actual
$0.84
EPS Est.
—
EPS Surpr.
—
Revenue
$0.76B
Q1 FY2024
Feb 18, 2024
EPS Actual
$0.99
EPS Est.
—
EPS Surpr.
—
Revenue
$0.76B
Q2 FY2023
Jun 30, 2023
EPS Actual
$0.80
EPS Est.
—
EPS Surpr.
—
Revenue
$0.71B
Q4 FY2022
Dec 31, 2022
EPS Actual
$0.74
EPS Est.
—
EPS Surpr.
—
Revenue
$0.61B
Q2 FY2022
Jun 30, 2022
EPS Actual
$0.63
EPS Est.
—
EPS Surpr.
—
Revenue
$0.57B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2026 | Feb 11, 2026 | — | $90.82 | $90.43 | -0.43% |
| — Q3 FY2025 | Aug 18, 2025 | — | $102.25 | $96.15 | -5.97% |
| — Q1 FY2025 | Feb 13, 2025 | — | $96.00 | $96.34 | +0.35% |
| — Q3 FY2024 | Aug 15, 2024 | — | $111.62 | $102.07 | -8.56% |
| — Q1 FY2024 | Feb 18, 2024 | — | $109.96 | $109.44 | -0.47% |
| — Q2 FY2023 | Jun 30, 2023 | — | $76.00 | $76.49 | +0.64% |
| — Q4 FY2022 | Dec 31, 2022 | — | $68.98 | $68.01 | -1.41% |
| — Q2 FY2022 | Jun 30, 2022 | — | $68.27 | $68.18 | -0.13% |
Q1 FY2026-0.43%
Report Date
Feb 11, 2026
EPS Beat/Miss
—
Price Before
$90.82
Price After
$90.43
Q3 FY2025-5.97%
Report Date
Aug 18, 2025
EPS Beat/Miss
—
Price Before
$102.25
Price After
$96.15
Q1 FY2025+0.35%
Report Date
Feb 13, 2025
EPS Beat/Miss
—
Price Before
$96.00
Price After
$96.34
Q3 FY2024-8.56%
Report Date
Aug 15, 2024
EPS Beat/Miss
—
Price Before
$111.62
Price After
$102.07
Q1 FY2024-0.47%
Report Date
Feb 18, 2024
EPS Beat/Miss
—
Price Before
$109.96
Price After
$109.44
Q2 FY2023+0.64%
Report Date
Jun 30, 2023
EPS Beat/Miss
—
Price Before
$76.00
Price After
$76.49
Q4 FY2022-1.41%
Report Date
Dec 31, 2022
EPS Beat/Miss
—
Price Before
$68.98
Price After
$68.01
Q2 FY2022-0.13%
Report Date
Jun 30, 2022
EPS Beat/Miss
—
Price Before
$68.27
Price After
$68.18
Beat Rate0 / 8 quarters
Largest Move-8.56% (Q3 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CHEOY ends December
Cochlear Limited (CHEOY) most recently reported earnings on February 11, 2026 for Q1 FY2026, posting EPS of $0.81 (in line with the analyst consensus of —). The next CHEOY earnings date is expected around September 1, 2026.
Each quarter, investors track CHEOY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CHEOY revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CHEOY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CHEOY earnings · 4 questionsCochlear Limited's next earnings report is expected around September 1, 2026. CHEOY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CHEOY historically reports after market close (AMC).
CHEOY earnings datewhen is CHEOY earningsCHEOY next earnings datewhen does CHEOY report earningsCHEOY earnings calendar
▸ Source: FMP · Cochlear Limited SEC filings · US GAAP · Cochlear Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026